Key Takeaways
- Amazon will stock Novo Nordisk’s Ozempic pill at US kiosks with same-day delivery starting in 2026.
- Same-day delivery initially covers roughly 3,000 locations, expanding to 4,500 by year-end.
- This move enhances access to GLP-1 diabetes treatments and complements Amazon Pharmacy’s expanding service portfolio.
Amazon announced on May 7, 2026, that its pharmacy will begin offering the Ozempic pill, produced by Novo Nordisk, at kiosks across the United States. The service includes same-day delivery aimed at improving patient access to treatment for type 2 diabetes. This initiative is part of Amazon Pharmacy’s ongoing efforts to broaden availability of GLP-1 therapies, including weight-loss medications like Wegovy and Eli Lilly’s Foundayo.
Amazon Pharmacy Boosts Diabetes Medication Accessibility Through Kiosks
Ozempic’s active compound, semaglutide, helps regulate blood sugar in people with type 2 diabetes by addressing insulin production and resistance issues. Although Amazon began offering GLP-1 drug delivery in 2021, it previously did not stock injectable forms at kiosks due to refrigeration requirements. The introduction of the pill version at approximately 3,000 kiosks nationwide represents a significant shift toward convenient medication pickup, backed by same-day delivery. Amazon plans to increase kiosk locations providing this service to around 4,500 by the end of 2026, covering roughly half of its US customer base.
Tanvi Patel, Amazon’s vice president, highlighted the company’s dedication to expanding treatment choices and simplifying access. Pricing for the Ozempic pill is set at $149 monthly for uninsured customers, while insured patients’ costs can be as low as $25.
Expanding Reach with Kiosks and One Medical Collaboration
Initially, Amazon deployed kiosks to improve access to commonly prescribed drugs such as antibiotics, blood pressure medications, and asthma inhalers. The platform now supports newer offerings like the Ozempic pill. In California, Wegovy tablets are currently available at five kiosks within Amazon’s One Medical facilities, where patients can collect prescriptions following health appointments. Notably, patients do not need a $199-per-year One Medical subscription to book appointments or use the kiosks.
Trump’s Tariffs May Spark an AI Gold Rush
While headlines focus on trade wars, our AI has identified one specific $1.5 trillion opportunity that remains completely overlooked. Take the 30-second assessment now to see if your trading profile matches this high-growth play before the opportunity expires.
SEE MY AI ASSESSMENT ➔This expansion aligns with Amazon’s broad strategy to diversify and triple its delivery options by 2026. Last year, the company invested over $4 billion to enhance logistics infrastructure and extend service to smaller towns and rural areas. Amazon’s introduction of oral GLP-1 medications addresses patient barriers such as refrigeration and shipping delays associated with injectable drugs. Concurrently, the pharmacy continues promoting Eli Lilly’s Foundayo weight-loss pill, positioning itself as a comprehensive provider of GLP-1-based therapies.
Pharmacy: Market Outlook
With same-day delivery available to approximately half of its US customers—including about 3,000 kiosks offering Ozempic—Amazon Pharmacy is poised to enhance treatment accessibility significantly this year. By integrating oral diabetes medications into physical retail locations, Amazon could reshape convenience standards in healthcare distribution. This development may increase competitive pressure on traditional pharmacies and influence GLP-1 medication supply chains.
By the end of 2026, Amazon plans to extend same-day delivery of Ozempic to nearly 4,500 kiosks, solidifying its role in the evolving pharmacy sector. Investors and industry observers will watch for implications on Novo Nordisk, Eli Lilly, and the broader telemedicine landscape catalyzed by Amazon’s healthcare initiatives.
